Background For cost utility analyses in health economic research it is necessary to assess quality of life for content validation. Previously, both quality of life questionnaires and utility indicators such as willingness to pay and time trade-off have been used successfully in patients with chronic skin diseases, such as psoriasis vulgaris or atopic eczema. Objective For the first time to assess willingness to pay and time trade-off in patients with port wine stains, and to study possible correlations between these indicators, patient income, quality of life questionnaires and subjective or objective outcome measures. Methods The results of a survey on 36 patients with facial lesions who had completed laser treatment were used for assessments. The ÔChronic Skin Disease QuestionnaireÕ (CSDQ) and the ÔShort Form-36 Health SurveyÕ (SF-36) were used as quality of life questionnaires. Special questions were used as a basis for calculating the utility indicators, willingness to pay and time trade-off. Results Completed questionnaires were sent back by 25 patients (69%). Willingness to pay and time trade-off were used as instruments for the assessment of quality of life [questions answered by 23 (92% of respondents)]; patients were willing to pay 11AE8% of their monthly income and would offer a mean value of 1AE2 h per day for an imaginary therapy leading to complete cure of the skin problem. Statistical correlation analyses were not performed because this pilot study included only a small number of patients. Frequency distributions show no apparent correlation between willingness to pay and patients' profession (used as a surrogate for income). Possible correlations were seen between willingness to pay, time trade-off, the scales Ôanxiety ⁄ avoidanceÕ and ÔhelplessnessÕ of the CSDQ as well as Ôsocial functionÕ of SF-36 and subjective or objective efficacy. Twenty-nine patients (80%) were willing to pay for the treatment, a surrogate measure for patients' satisfaction with treatment modality. Overall, patients would pay an average of e16AE0 per single treatment and e192AE0 for the whole course of treatments. In contrast with patients who evaluated treatment modality as excellent or very good (willingness to pay for single treatment, e22AE0; for whole treatment, e270AE0), patients who judged treatment good (e8AE0, e145AE0), moderate or bad (e12AE0, e146AE0) were willing to pay markedly less. Conclusions (i) The questions for willingness to pay and time trade-off were understood by most patients and produced meaningful answers. (ii) There were apparent correlations between the utility indicators, subjective or objective outcome and the scales of the quality of life questionnaires. (iii) The results show that these indicators have a high potential for use in this dermatological condition, especially as a basis for health economic evaluations.
Port wine stains are congenital vascular malformations with an incidence of 2% of births. 1 As malignant transformation occurs only very rarely, 2, 3 patients mainly suffer from cosmetic problems especially when lesions are located on the face. Two recent studies analysed impairment of quality of life in patients with port wine stains. 4, 5 Augustin et al. found skin-specific coping with disease, especially in the areas social anxiety ⁄ avoidance, feeling of helplessness and anxious-depressive moods, similar to that seen in patients with chronic skin diseases such as psoriasis vulgaris or atopic dermatitis. 4 Shakespeare et al. evaluated the influence of laser treatment on quality of life and observed a significant improvement in mental health after therapy. 5 Instruments used for measuring quality of life were the disease-specific Chronic Skin Disease Questionnaire (CSDQ) (in the German Version as Marburger Hautfragebogen) 6, 7 and the Short Form-36 Health Survey (SF-36) as a general health status questionnaire. 8 Nevertheless, at present there is no accepted standard for the assessment of quality of life in patients with port wine stains. The evaluation of quality of life is specially indicated for health economic analyses that are based on three components: (i) the assessment of clinical efficacy; (ii) the influence on quality of life; and (iii) short-term and long-term therapy costs. [9] [10] [11] [12] In earlier studies indicators such as willingness to pay and time trade-off, expressed as utilities, 10, [13] [14] [15] [16] [17] provided useful data in patients with psoriasis vulgaris. [18] [19] [20] Furthermore they could show advantages when compared with quality of life questionnaires: (i) quick and easy assessment; (ii) comparability of results between different diseases; and (iii) more suitable data for health economic evaluations. To assess, for the first time, willingness to pay and time trade-off in patients with port wine stains, we performed a study to evaluate patient acceptance and possible correlations between the utility indicators, patient income, quality of life questionnaires and subjective or objective outcome measurements of treatment.
Materials and methods

Study design
This was a cross-sectional study in patients with port wine stains located on the face who had completed laser treatment. We surveyed the patients with a questionnaire accompanied by a letter to explain the purpose of the study and thank the patient for participating.
Assessments
The assessments comprised: 1 Sex, age and profession. 2 The clinical appearance of the port wine stain and the clearance of colour after treatment (> 95%, 76-95%, 51-75%, 25-50%, < 25%), the number of treatment sessions and type of lasers used. 3 The patient's satisfaction with the clinical outcome, a subjective impression of improvement of cosmetic appearance using a rating scale (very good, good, moderate, bad, very bad); the patient's satisfaction with treatment modality, a subjective impression of the effects and side-effects of laser treatment (excellent, very good, good, moderate, bad). 4 Two quality of life questionnaires: (i) the skin-specific questionnaire, CSDQ (Appendix 1), 4, 6, 7 and (ii) the SF-36 in the German version (Appendix 1).
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5 Utility questions. Utilities are cardinal values that are assigned to each health state on a scale that is established by assigning a value between 0 and 1 (in our case: willingness to pay ranged between 0% of monthly income (i.e. no reduction of quality of life by the disease) and 100% of monthly income (i.e. maximum reduction of quality of life), whereas time tradeoff ranged between 0 h per day (i.e. no reduction of quality of life by the disease) and 24 h per day (i.e. maximum reduction of quality of life). Utility values reflect the quality of the health states and allow morbidity improvements to be combined into a single weighted measure. 16 The questions assessed: 1 Willingness to pay as a quality of life instrument. Willingness to pay in the classical sense is a parameter for the evaluation of quality of life assessed by asking the patients how much money they would be willing to pay for an imaginary therapy that would be able to relieve their disease. In theory, the more the patients are willing to pay, the more they are impaired in their quality of life by the disease and vice versa. Willingness to pay was assessed with a specially developed question (Appendix 2). 20 2 Time trade-off as a quality of life instrument. The classical principle of time trade-off assesses how much a patient is willing to offer from their remaining life expectancy for an imaginary therapy that would release them from their disease for the rest of their life. The more the patient is willing to offer, the higher the
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burden of the disease and the lower the present quality of life. The method was slightly modified by asking the patient to give a percentage of hours per day he ⁄ she would be willing to offer for the imaginary therapy, rather than the percentage of remaining life expectancy. This modification seemed necessary to provide the patient with a more realistic time schedule that was easier to imagine. Time trade-off was assessed with a question that we developed (Appendix 2). 20 3 Willingness to pay as a measure of patients' satisfaction with the treatment modality. Willingness to pay can also be used for assessment of the patient's satisfaction with treatment. The more a patient is willing to pay, the more content he ⁄ she is with the treatment. Willingness to pay was assessed with a question using clusters of payment sums (Appendix 2).
For the analysis of mean values of willingness to pay per treatment the minimum value of each possible group was used (i.e. e11AE0 for a patient who chooses to pay e11-15AE0 for a single treatment session). For assessment of willingness to pay for the whole treatment, willingness to pay per treatment was multiplied by the number of treatments performed per patient.
Statistics
Descriptive statistics were calculated for each assessment. Because the number of patients in this study was small, statistical correlation analyses were not performed. Potential correlations were analysed using frequency distributions with very small numbers combined into groups (e.g. patients who evaluated their satisfaction with clinical outcome as moderate or bad were combined in one group).
Results
Patient characteristics
The survey was sent out to 42 patients in January 2001. Six patients had moved house since completing treatment; therefore, only 36 questionnaires reached the patients. Twenty-five surveys (69%) were returned and could be analysed. Thirteen patients were male and 12 female, with a mean age of 42 years. The distribution of professions provided seven workmen, nine employees, four self-employed, three housewives, one pensioner and one student.
Port wine stains were located on the face in 24 patients and on the head and neck in one patient. In 21 the lesion was smaller, in four larger than 100 cm 2 . The colour of the lesions varied as follows: Ôlight redÕ in two patients (8%), ÔredÕ in seven (28%) and Ôdark redÕ in 16 (64%).
Treatment and clinical clearance
Flashlamp-pumped pulsed dye and argon lasers were used for treatment depending on the clinical criteria and need for each individual patient. Patients were treated until no incremental progression in clinical efficacy could be seen. On average, 19AE7 treatments per patient were performed (range 4-87). Clinical efficacy was evaluated as clinical clearance of colour compared with the appearance at the beginning of treatment: clearance of more than 95% in two patients (8%), 76-95% in seven (28%), 51-75% in 11 (44%) and 25-50% in five (20%).
Patients' satisfaction with clinical outcome and treatment modality
All 25 patients answered the questions: five (20%) assessed their satisfaction with clinical outcome as very good, six (24%) as good, 11 (44%) as moderate and three (12%) as bad. Satisfaction with treatment modality was distributed as follows: excellent or very good in 13 (52%), good in six (24%) and moderate or bad in six (24%) of patients.
Quality of life questionnaires
Chronic Skin Disease Questionnaire. The data of all 25 patients could be analysed. The mean rating of Ôanxiety ⁄ avoidanceÕ (scale 1) was 31 (range , that of Ôitching-scratching-circleÕ (scale 2) was 9AE5 (range 9-14), ÔhelplessnessÕ (scale 3) was 20AE2 (range 9-41) and Ôanxious depressive moodsÕ (scale 4) was 13AE9 (range 8-26). As found by Augustin et al., 4 only scales 1, 3 and 4 could be used for analysis. As expected, scale 2 (Ôitching-scratching-circleÕ) showed no impairment in patients with port wine stains. In comparison with patients with port wine stains still in treatment 4 or with patients with other chronic skin diseases, our patients showed slightly lower values in all three CSDQ scales used ( Table 1 ). As our patients were surveyed after the completion of treatment, this finding, suggesting improved coping with disease, is not surprising. Nevertheless in most cases treatment could not achieve a complete disappearance of lesions and, therefore, an impairment in quality of life still existed.
The frequency distribution of patients' satisfaction with the clinical outcome indicates an apparent correlation with values of scales 1 and 3 (Ôanxiety ⁄ avoidanceÕ (Fig. 1) .
Short Form 36 Health Survey. Single scales of the SF-36 could not be analysed for all patients because of missing values. Detailed data are given in Table 2 . As is to be expected, scales 1, 2 and 3 (Ôphysical functionÕ, Ôphysical roleÕ and Ôbodily painÕ) were not influenced by port wine stains and the values observed do not differ from those of the normal population. Slight impairment in quality of life in comparison with the normal population (5-10% below the norm) could be observed in scales 4, 6 and 7 (Ôgeneral healthÕ, Ôsocial functionÕ and Ôemotional roleÕ). Marked impairment (> 10% below the norm) was observed in scales 5 and 8 (ÔvitalityÕ and Ômental healthÕ).
A comparison of SF-36 items between our patients and other post-treatment data 5 shows similar values in the items Ômental healthÕ and ÔvitalityÕ, slightly lower values for Ôgeneral healthÕ, but higher values in the following items: Ôphysical and social functionÕ, Ôphysical and emotional roleÕ and Ôbodily painÕ ( Table 2 ).
The frequency distribution of patients' satisfaction with clinical outcome related to values of SF-36 items show a positive correlation only for scale 6 (Ôsocial functionÕ). Patients with a higher satisfaction showed a higher value (very good satisfaction: 91), patients with lower satisfaction a lower value (moderate or bad satisfaction: 84) in this scale (Fig. 2) . 
Utility questions
Willingness to pay as a quality of life instrument. The answers of 23 patients (92%) could be analysed. On average patients were willing to pay 11AE8% ± 19AE7% (range 1-100%) of their monthly income for an imaginary therapy that would completely relieve them of their complaints caused by this disease. The frequency distributions showed no correlation between willingness to pay and patients' profession, which might influence the percentage or sum of money that patients were willing to pay. Although pensioners, housewives or students do not really earn more money than workmen, employees or self-employed people, in this survey they wanted to pay most.
As found with the quality of life questionnaire scales, the frequency distribution of patients' satisfaction with clinical outcome related to willingness to pay suggests a positive correlation; patients with a higher satisfaction (very good satisfaction: 4% of monthly income) would pay less for the imaginary therapy than patients with lower satisfaction (moderate or bad satisfaction: 16% of income). This again indicates more impairment in quality of life after treatment in those patients who were not satisfied with the treatment (Fig. 3) . Similar results were seen in the frequency distribution concerning willingness to pay and the clinical clearance of colour noted by the dermatologists.
Time trade-off as a quality of life instrument. The replies of 20 patients (80%) could be analysed. On average patients were willing to offer 1AE2 ± 0AE9 h per day (range 0AE3-4AE5 h per day) for an imaginary therapy with complete cure. As with the data on willingness to pay, the frequency distributions of patients' satisfaction of time trade-off related to clinical outcome or clinical clearance of colour noted by the dermatologists suggest a positive correlation; again patients with a higher satisfaction or better clearance would offer less time than most patients with lower satisfaction (Fig. 4) .
Willingness to pay as a measure of patient satisfaction with treatment modality. The replies of 20 patients (80%) could be analysed; 80% of patients were willing to pay for the treatment. On average, patients would pay e16AE0 per single treatment (< e5AE0: n ¼ 3; e5-10AE0: n ¼ 4; e11-15AE0: n ¼ 2; e16-20AE0: n ¼ 0; e21-25AE0: n ¼ 3; > e25AE0: n ¼ 8) and e192AE0 for the whole treatment (range e4AE0-834AE0). In contrast with patients who evaluated treatment modality as excellent or very good (willingness to pay for single treatment e22AE0, or whole treatment e270AE0), patients who judged treatment good (e8AE0, 145AE0), moderate or bad (e 12AE0, 146AE0) would pay markedly less indicating a positive correlation between satisfaction and willingness to pay.
Discussion
The results of this study in patients with port wine stains treated with lasers show that, in principle, all the utility questions used to assess patients' impairment in quality of life (willingness to pay and time trade-off) and patients' satisfaction with treatment modality (willingness to pay) were understood by the patients and transformed into meaningful answers. This corresponds to our own experiences with similar questions in surveys performed in patients suffering from psoriasis vulgaris 20 and to data from the literature. 18, 19 Most patients answered all the questions; however, more patients answered the willingness to pay question as an instrument of assessment of quality of life than the time trade-off question-23 (92%) vs. 20 (80%). This might be caused by the fact that it is more common for people to handle money than time. Evaluation of willingness to pay is often supposed to depend on the income of the persons asked. To minimize this problem we modified the question by asking for the percentage of income instead of absolute monetary values. Furthermore, frequency distributions showed no signs of possible correlation between profession and willingness to pay. This is important to avoid a bias in the results.
As for the results of the quality of life questionnaires used in this survey, we found that the CSDQ subscales and SF-36 items had similar values to those of Augustin et al. 4 and Shakespeare et al. 5 Differences, especially in CSDQ scales, which show better coping with disease in our patients, might be due to the time when patients were studied, after treatment was completed. Even though patients profited from treatment, complete remission was not achieved in anyone. This lack of success is reflected in the impairment of quality of life, especially in the subscales Ôsocial anxiety ⁄ avoidanceÕ and ÔhelplessnessÕ of the CSDQ and in the psychological scales of SF-36 Ômental healthÕ and ÔvitalityÕ. Both willingness to pay and time trade-off also revealed this impairment of quality of life in the patients. After treatment, patients were still willing to pay 11AE8% of their monthly income on average for an imaginary therapy that would completely relieve them of their complaints. Surprisingly the mean value was similar to that found in a survey performed in 105 patients suffering from psoriasis vulgaris after treatment (willingness to pay: 12AE4% of monthly income). 20 On average patients were willing to give up 1AE2 h per day for an imaginary therapy that completely cured the disease (time trade-off principle). For example with a daily time schedule of about 8 h sleep and 10 h work, including driving time, patients would offer about 20% of the rest of the day's time, 1AE2 h. In comparison with patients suffering from psoriasis vulgaris who would offer 3AE3 h per day in a survey that used the same question, 19 the time trade-off found here was markedly lower. In their survey, Finlay and Coles 18 evaluated a mean time trade-off of 1 h per day in patients with psoriasis vulgaris. Therefore we need more data, in other dermatological conditions, to evaluate the possible range of utilities as assessment instruments and their value for estimating quality of life.
Although no statistical correlations were performed because of the small number of patients in this study, there were apparent correlations between willingness to pay, time trade-off and treatment success as measured by patients' satisfaction with clinical outcome and clearance of colour after treatment. The difference in willingness to pay and time trade-off between patients with good and moderate treatment success was remarkable.
Evaluation of willingness to pay as an instrument for patients' satisfaction with treatment modality can help to answer the question of how much personal value a treatment has for the patient, and whether and how much he ⁄ she would pay to get a special treatment. This might be meaningful for the health economic comparison of different treatment strategies with similar clinical outcomes, for the evaluation of expected compliance to a new treatment modality or for economic estimations of sums of willingness to pay, especially in aesthetic indications, such as in laser treatment. Although patients in our study were not completely relieved of their condition, 80% would pay for this treatment. Owing to lack of data about willingness to pay for other dermatological treatments it is not currently possible to compare the evaluated sums; therefore, further evaluations are necessary.
Although it may not be concluded that the implementation of willingness to pay or time trade-off questions can replace a quality of life questionnaire, the positive results of the present study indicate that, especially for health economic evaluations, the principles of willingness to pay and time trade-off bear a high potential for use also in this dermatological condition.
